Puhe Pharmaceutical Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Investors
  • 6

Puhe Pharmaceutical General Information

Description

Operator of a pharmaceutical company intended to develop innovative small-molecule drugs. The company offers a pipeline of clinical-stage drugs focused on targeted therapies, enabling patients to get proper treatment of their diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 108, Yuxin Road
  • Suzhou Industrial Park
  • Suzhou, Jiangsu 215000
  • China
+86 0521
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Number 108, Yuxin Road
  • Suzhou Industrial Park
  • Suzhou, Jiangsu 215000
  • China
+86 0521

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Puhe Pharmaceutical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 25-Sep-2025 Completed Generating Revenue
1. Secondary Transaction - Private 23-Dec-2021 Completed Startup
To view Puhe Pharmaceutical’s complete valuation and funding history, request access »

Puhe Pharmaceutical Patents

Puhe Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026214690-A1 Mat2a inhibitor Pending 10-Apr-2025
WO-2026208920-A1 Pyrimidinylaminobenzenes for treating cancer with an egfr pacc mutation Pending 02-Apr-2025
WO-2026153427-A1 Polycyclic compound functioning as mat2a inhibitor Pending 17-Jan-2025
WO-2026130474-A1 Macrocyclic compound as pan-ras mutant inhibitor Pending 20-Dec-2024
WO-2025201480-A1 Spiro compound as kras mutant inhibitor Pending 28-Mar-2024
To view Puhe Pharmaceutical’s complete patent history, request access »

Puhe Pharmaceutical Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
CAS Star Venture Capital Minority
Hankang Capital Growth/Expansion Minority
Suzhou Equity Investment Fund Management Fund of Funds Minority
Trinity Innovation Fund Venture Capital Minority
YuanBio Venture Capital Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Puhe Pharmaceutical FAQs

  • When was Puhe Pharmaceutical founded?

    Puhe Pharmaceutical was founded in 2020.

  • Where is Puhe Pharmaceutical headquartered?

    Puhe Pharmaceutical is headquartered in Suzhou, China.

  • What industry is Puhe Pharmaceutical in?

    Puhe Pharmaceutical’s primary industry is Drug Discovery.

  • Is Puhe Pharmaceutical a private or public company?

    Puhe Pharmaceutical is a Private company.

  • What is Puhe Pharmaceutical’s current revenue?

    The current revenue for Puhe Pharmaceutical is .

  • Who are Puhe Pharmaceutical’s investors?

    CAS Star, Hankang Capital, Suzhou Equity Investment Fund Management, Trinity Innovation Fund, and YuanBio Venture Capital are 5 of 6 investors who have invested in Puhe Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process